Date
- Wednesday, 16 June 2010, All day
Location
- European Medicines Agency, Amsterdam, the Netherlands
The meeting covered the following topics: revision of the mandate and rules of procedure of the PCWP; the interaction between the Agency and health technology assessment bodies; the interaction between the Agency and patient & consumer organisations; direct reporting of adverse events by patients.